Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00256711
What this trial is testing

Phase II Iressa Versus Vinorelbine (INVITE)

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 192
Testing effectiveness (Phase 2)Study completedNCT00637026
What this trial is testing

Ph II Early BC Pre-Surgical Biologic Study

Who this might be right for
Breast Cancer
AstraZeneca 65
Not applicableStudy completedNCT01818947
What this trial is testing

Gefitinib Usage and Outcomes in Routine Treatment

Who this might be right for
Lung Cancer
AstraZeneca 157
Large-scale testing (Phase 3)Study completedNCT00206219
What this trial is testing

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 477
Large-scale testing (Phase 3)UnknownNCT02929693
What this trial is testing

Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

Who this might be right for
Cancer
Shanghai University of Traditional Chinese Medicine 198
Testing effectiveness (Phase 2)UnknownNCT01291823
What this trial is testing

Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Zhejiang Cancer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00319618
What this trial is testing

Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 66
Testing effectiveness (Phase 2)Ended earlyNCT00483561
What this trial is testing

Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Nebraska 26
Testing effectiveness (Phase 2)Study completedNCT01466660
What this trial is testing

LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung

Who this might be right for
Lung Neoplasms
Boehringer Ingelheim 319
Testing effectiveness (Phase 2)Ended earlyNCT02025218
What this trial is testing

Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients

Who this might be right for
Lung Cancer
Amsterdam UMC, location VUmc 21
Early research (Phase 1)Study completedNCT00186979
What this trial is testing

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

Who this might be right for
Solid Tumors
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00080743
What this trial is testing

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 2
Large-scale testing (Phase 3)UnknownNCT00006048
What this trial is testing

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
AstraZeneca
Testing effectiveness (Phase 2)UnknownNCT01932229
What this trial is testing

An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib

Who this might be right for
NSCLC
Sheba Medical Center 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03787992
What this trial is testing

Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）

Who this might be right for
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc. 358
Large-scale testing (Phase 3)Study completedNCT00020709
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more
National Cancer Institute (NCI) 840
Testing effectiveness (Phase 2)WithdrawnNCT00233636
What this trial is testing

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerCarcinoma, Squamous Cell
AstraZeneca 28
Large-scale testing (Phase 3)Ended earlyNCT00352079
What this trial is testing

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Who this might be right for
Bladder Cancer
NCIC Clinical Trials Group 41
Not applicableEnded earlyNCT01363557
What this trial is testing

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

Who this might be right for
EGFR-mutated Lung AdenocarcinomaBrain Metastasis
Assistance Publique - Hôpitaux de Paris 1
Large-scale testing (Phase 3)Study completedNCT04248829
What this trial is testing

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Who this might be right for
Non-Small Cell Lung Cancer
Yuhan Corporation 393
Next Page